Home > Breaking News > 2017 SFTS Congress

2017 SFTS CONGRESS IN bordeaux

 

The French Blood Transfusion Society congress (S.F.T.S.) takes place every 2 years. This year, the 28th edition of this national congress will be held in Bordeaux from September 20th to 22nd. This congress is the main meeting for french blood transfusion professionals but also prescribers, researchers, scientists and health professionals associated with the transfusional medicine. It also represents an unique opportunity for French (and French speaking) blood transfusion experts to meet, exchange and share experiences. As a major actor of blood transfusion, DIAGAST will be present.

 

First, on its booth no 71, our sales and scientific teams will meet you to provide information and answers about highlighted products and services by our company:

QWALYS EVO

After its official launching in Copenhagen ISBT Congress last june, QWALYS® EVO, will be introduced to the professional of french biology, notably introducing a "real" STAT function enabling users to further improve time to results.

 

ABTest® card

The focus will be also placed on our "Transfusion Safety" range and more specifically ABTest® Card (more information). This bedside card is using an innovative technlogy  M-TRAP and can bring to users a simple, secure and fast technique with reliable and standardizes results.

 

On the other hand, a symposium will be organized on the  theme  "DIAGAST INNOVATES' with:

 

ABD PAD®

EM® Technology and QWALYS® : the next generation

Study of performance
and ergonomics

Presentation of the biology
and the automate

Routine performance
evaluation

by Dr Emmanuel RIVERY
 EFS Pays de Loire, Nantes site
s

by Mrs Christine BETREMIEUX
Scientific Affairs Manager, DIAGAST

by Mrs Fanny DENIS
Product manager, DIAGAST

 

on Wednesday, September 20 from 12:45 to 13:45, rooms E1-E2

 

We hope lots of you will come!

 

Self sufficiency and security will be the watchwords of this congress. In fact, transfusion requirements increase and the availability of products is difficult to follow. This difficulty is recognized in France as well as in Europe. However, blood safety really means product quality and self-sufficiency capacity, to cover all needs, and in real time.

On the other hand, the study of the difference between supply and needs, namely the improvement of requirements, development of new biotechnologies, particularly those based on cell therapy is essential. All these ways of development, research and reference should lead to increase the safety of transfused blood products.Autosuffisance et sécurité seront les maîtres mots de ce congrès.

Follow us: Follow us on FacebookFacebook Suivez-nous sur YoutubeYoutube Follow our newsRSS
Last update : 23/11/2017 10:26:52